Using deep learning to identify bladder cancers with FGFR ‐activating mutations from histology images

Melanomas with activating RAF1 fusions: clinical, histopathologic, and molecular profiles

(2020) Erik A. Williams et al.   MODERN PATHOLOGY

Deep learning outperformed 136 of 157 dermatologists in a head-to-head dermoscopic melanoma image classification task

(2019) Titus J. Brinker et al.   EUROPEAN JOURNAL OF CANCER

Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma

(2019) Yohann Loriot et al.   NEW ENGLAND JOURNAL OF MEDICINE

A convolutional neural network-based system to prevent patient misidentification in FDG-PET examinations

(2019) Keisuke Kawauchi et al.   Scientific Reports

Man against machine: diagnostic performance of a deep learning convolutional neural network for dermoscopic melanoma recognition in comparison to 58 dermatologists

(2018) H A Haenssle et al.   ANNALS OF ONCOLOGY

Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images

(2018) Joel Saltz et al.   Cell Reports

Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection

(2018) Clare Fiala et al.   BMC Medicine

T Cell–Inflamed versus Non-T Cell–Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection

(2018) Jonathan A. Trujillo et al.   Cancer Immunology Research

Dermatologist-level classification of skin cancer with deep neural networks

(2017) Andre Esteva et al.   NATURE

Deep Convolutional Neural Networks and Learning ECG Features for Screening Paroxysmal Atrial Fibrillation Patients

(2017) Bahareh Pourbabaee et al.   IEEE Transactions on Systems Man Cybernetics-Systems

Toward a Shared Vision for Cancer Genomic Data

(2016) Robert L. Grossman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Molecular Drivers of the Non-T-cell-Inflamed Tumor Microenvironment in Urothelial Bladder Cancer

(2016) R. F. Sweis et al.   Cancer Immunology Research

The FGFR Landscape in Cancer: Analysis of 4,853 Tumors by Next-Generation Sequencing

(2015) T. Helsten et al.   CLINICAL CANCER RESEARCH

Fibroblast Growth Factor Receptor 3 Is a Rational Therapeutic Target in Bladder Cancer

(2013) K. M. Gust et al.   MOLECULAR CANCER THERAPEUTICS

Roles of Fibroblast Growth Factor Receptors in Carcinogenesis

(2010) E. M. Haugsten et al.   MOLECULAR CANCER RESEARCH